Metabolic contrasts between youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes: I. Observations using the hyperglycemic Clamp

Diabetes Care

Volumn 41, Issue 8, 2018, Pages 1696-1706

  Edelstein, Sharon L ^a   Kahn, Steven E ^a   Arslanian, Silva A ^a   Buchanan, Thomas A ^a   Ehrmann, David A ^a   Nadeau, Kristen J ^a   Palmer, Jerry P ^a   Utzschneider, Kristina M ^a  

^a Westat   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; C PEPTIDE; GLUCOSE; INSULIN;

ADOLESCENT; ADULT; CHILD; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIC CLAMP TECHNIQUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN CLEARANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PANCREAS ISLET BETA CELL; STEADY STATE; AGED; BLOOD; DIET RESTRICTION; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; C-PEPTIDE; CHILD; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 85052083808     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc18-0244     Document Type: Conference Paper

References (30)

1. Ogurtsova K, daRocha Fernandes JD, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract 2017; 128:40-50
2. Mayer-Davis EJ, Lawrence JM, Dabelea D, et al.; SEARCH for Diabetes in Youth Study. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017; 376:1419-1429
3. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017 [article online], 2017. Available from https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Accessed 18 July 2017
4. World Health Organzation. Global Health Observatory (GHO) data. Overweight and obesity [Internet], 2017. Available from http://www.who.int/gho/ncd/risk-factors/overweight/en/. Accessed 24 August 2017
5. Hales CM, Fryar CD, Carroll MD, Freedman DS, Ogden CL. Trends in obesity and severe obesity prevalence in US youth and adults by sex and age, 2007-2008 to 2015-2016. JAMA 2018; 319:1723-1725
6. Jensen CC, Cnop M, Hull RL, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group. β-Cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002; 51:2170-2178
7. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest 2005; 115:485-491
8. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. β-Cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005; 54:1735-1743
9. Burns SF, Bacha F, Lee SJ, Tfayli H, Gungor N, Arslanian SA. Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic rangein overweight youth. Diabetes Care 2011; 34:2033-2040
10. TODAY Study Group. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012; 366:2247-2256
11. Kahn SE, Haffner SM, Heise MA, et al.; ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006; 355:2427-2443
12. TODAY Study Group. Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and β-cell function in TODAY. Diabetes Care 2013; 36:1749-1757
13. The RISE Consortium. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span. Diabetes Care 2014; 37:780-788
14. Andres R, Swerdloff R, Posefsky T, Coleman DL. Manual feedback technique for the control of blood glucose concentration. In Automation in Analytical Chemistry. Skeegs LT Jr., Ed. New York, Mediad, 1966, p. 486-491
15. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. AmJ Physiol 1979; 237:E214-E223
16. Elahi D. Inpraise of the hyperglycemic clamp. A method for assessment of β-cell sensitivity and insulin resistance. Diabetes Care 1996; 19:278-286
17. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993; 42:1663-1672
18. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 1984; 74:1318-1328
19. Castillo MJ, Scheen AJ, Letiexhe MR, Lefèbvre PJ. How to measure insulin clearance. Diabetes Metab Rev 1994; 10:119-150
20. Peterson CM, Su H, Thomas DM, et al. Triponderal mass index vs body mass index in estimating body fat during adolescence. JAMA Pediatr 2017; 171:629-636
21. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab 1991; 72:277-282
22. Hannon TS, Janosky J, Arslanian SA. Longitudinal study of physiologic insulin resistance and metabolic changes of puberty. Pediatr Res 2006; 60:759-763
23. Curry DL, Bennett LL, Grodsky GM. Dynamics of insulin secretion by the perfused rat pancreas. Endocrinology 1968; 83:572-584
24. Chen ME, Chandramouli AG, Considine RV, Hannon TS, Mather KJ. Comparison of β-cell function between overweight/obese adults and adolescents across the spectrum of glycemia. Diabetes Care 2018; 41:318-325
25. Brunzell JD, Robertson RP, Lerner RL, et al. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. J Clin Endocrinol Metab 1976; 42:222-229
26. Metz SA, Halter JB, Robertson RP. Paradoxical inhibition of insulin secretion by glucose in human diabetesmellitus. J Clin Endocrinol Metab 1979; 48:827-835
27. Kelsey MM, Forster JE, Van Pelt RE, Reusch JE, Nadeau KJ. Adiposetissue insulin resistance in adolescents with and without type 2 diabetes. Pediatr Obes 2014; 9:373-380
28. Arslanian S, Kim JY, Nasr A, et al. Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: who is worse off? Pediatr Diabetes 2018; 19:205-211
29. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol 1981; 240:E630-E639
30. Buchanan TA, Xiang AH, Peters RK, et al. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes 2002; 51:2796-2803